Table 3.
Summary measures of patient profiles for primary and secondary outcomes stratified by intervention group
| Outcome Measure | Follow -up | TAU | CCBT | ||||||
|---|---|---|---|---|---|---|---|---|---|
| BDI | n | Mean(SD) | Median(IQR) | Min-Max | n | Mean(SD) | Median(IQR) | Min-Max | |
| Baseline | 12 | 23.3(5.2) | 24.5(19.0-28.5) | 15.0-29.0 | 12 | 21.0(4.0) | 22.0(17.0-25.0) | 16.0-27.0 | |
| 8 weeks | 12 | 22.1(9.1) | 20.0(18.0-25.0) | 7.0-44.0 | 9 | 14.8(7.5) | 16.0(8.0-21.0) | 6.0-26.0 | |
| 21 weeks | 8 | 24.4(11.4) | 21.5(18.0-33.0) | 8.0-42.0 | 10 | 18.3(7.9) | 17.0(11.0-24.0) | 10.0-35.0 | |
| MSIS-29 subscale | |||||||||
| Physical | Baseline | 11 | 60.7(20.9 | 68.0(38.0-78.0) | 32.0-94.0 | 12 | 62.8(14.2) | 65.0(50.5-71.5) | 42.0-87.0 |
| 8 weeks | 12 | 58.3(18.7) | 60.5(42.5-74.0) | 30.0-85.0 | 8 | 58.8(19.0) | 65.5(40.0-71.0) | 33.0-84.0 | |
| 21 weeks | 10 | 60.8(22.0) | 57.5(44.0-81.0) | 31.0-97.0 | 9 | 55.8(18.0) | 58.0(43.0-65.0) | 27.0-82.0 | |
| Psychological | Baseline | 11 | 27.3(8.2) | 28.0(20.0-37.0) | 15.0-38.0 | 12 | 28.8(6.2) | 29.5(24.5-34.0) | 18.0-37.0 |
| 8 weeks | 12 | 26.8(8.9) | 27.5(20.0-33.0) | 14.0-43.0 | 8 | 23.4(10.3 | 25.5(13.0-29.5) | 11.0-40.0 | |
| 21 weeks | 10 | 25.7(9.5) | 24.0(16.0-33.0) | 15.0-43.0 | 9 | 24.4(6.6) | 22.0(21.0-31.0) | 17.0-34.0 | |